Cargando…

Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure

BACKGROUND: Wilson’s disease is a genetic disorder inherited in a recessive manner, caused by mutations in the copper-transporter ATP7B. Although it is a well-known disease, currently available treatments are far from satisfactory and their efficacy varies in individual patients. Due to the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeląg-Pieniek, Sylwia, Oswald, Stefan, Post, Mariola, Łapczuk-Romańska, Joanna, Droździk, Marek, Kurzawski, Mateusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460590/ https://www.ncbi.nlm.nih.gov/pubmed/34117631 http://dx.doi.org/10.1007/s43440-021-00290-8

Ejemplares similares

Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021)

Protein Abundance of Drug Transporters in Human Hepatitis C Livers
por: Droździk, Marek, et al.
Publicado: (2022)

Protein Abundance of Drug Metabolizing Enzymes in Human Hepatitis C Livers
por: Drozdzik, Marek, et al.
Publicado: (2023)

The reference liver—CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype
por: Kurzawski, Mateusz, et al.
Publicado: (2021)

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology
por: Droździk, Marek, et al.
Publicado: (2020)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases
por: Gholizadeh, Maryam, et al.
Publicado: (2020)

Membrane Transporters in Human Parotid Gland-Targeted Proteomics Approach
por: Lapczuk-Romanska, Joanna, et al.
Publicado: (2019)

A Mixture Method for Robust Detection HCV Early Diagnosis Biomarker with ML Approach and Molecular Docking
por: Gholizadeh, Maryam, et al.
Publicado: (2023)

Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract
por: Droździk, Marek, et al.
Publicado: (2020)

Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus
por: Kurzawski, Mateusz, et al.
Publicado: (2012)

Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
por: Klomp, Florian, et al.
Publicado: (2020)

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
por: Droździk, Marek, et al.
Publicado: (2013)

Intestinal drug transporters in pathological states: an overview
por: Drozdzik, Marek, et al.
Publicado: (2020)

Antibacterial performance of nanocrystallined titania confined in mesoporous silica nanotubes
por: Cendrowski, Krzysztof, et al.
Publicado: (2014)

Membrane Carriers and Transporters in Kidney Physiology and Disease
por: Drozdzik, Marek, et al.
Publicado: (2021)

Association study of folate-related enzymes (MTHFR, MTR, MTRR) genetic variants with non-obstructive male infertility in a Polish population
por: Kurzawski, Mateusz, et al.
Publicado: (2015)

Drug-Induced Gingival Overgrowth—Molecular Aspects of Drug Actions
por: Droździk, Agnieszka, et al.
Publicado: (2023)

Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?
por: Wenzel, Christoph, et al.
Publicado: (2021)

Effect of the ADRB1 1165C>G and 145A>G polymorphisms on hemodynamic response during dobutamine stress echocardiography
por: Banaś, Anna, et al.
Publicado: (2011)

Epigenetic Regulations of AhR in the Aspect of Immunomodulation
por: Wajda, Anna, et al.
Publicado: (2020)

Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1
por: Römer, Sarah, et al.
Publicado: (2021)

Analysis of selected genetic variants in psoriasis susceptibility and response to treatment
por: Malinowski, Damian, et al.
Publicado: (2022)

TGFβ3 (TGFB3) polymorphism is associated with male infertility
por: Droździk, Marek, et al.
Publicado: (2015)

The Role of Nrf2 in Pathology of Pleomorphic Adenoma in Parotid Gland
por: Droździk, Agnieszka, et al.
Publicado: (2015)

Gene Expression Variability in Human Hepatic Drug Metabolizing Enzymes and Transporters
por: Yang, Lun, et al.
Publicado: (2013)

CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers
por: Gawrońska-Szklarz, Barbara, et al.
Publicado: (2012)

Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma – a preliminary study
por: Vlaykova, Tatyana, et al.
Publicado: (2014)

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2019)

Mechanisms of promiscuity among drug metabolizing enzymes and drug transporters
por: Atkins, William M.
Publicado: (2019)

Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
por: Vasilogianni, Areti‐Maria, et al.
Publicado: (2022)

Hepatic encephalopathy in Wilson's disease
por: Pawaskar, Rachhanaa Satish, et al.
Publicado: (2020)

Influence of variation in the catechol-O-methyltransferase gene on the clinical outcome after lumbar spine surgery for one-level symptomatic disc disease: a report on 176 cases
por: Rut, Marcin, et al.
Publicado: (2013)

Effect of interleukin 6 –174G>C gene polymorphism on opioid requirements after total hip replacement
por: Białecka, Monika, et al.
Publicado: (2016)

Current Drug Managements of Wilson's Disease: From West to East
por: Li, Wen-Jie, et al.
Publicado: (2016)

Emergent Living Donor Liver Transplantation for Fulminant Hepatic Failure Secondary to Wilson’s Disease
por: Kumar, Shiva
Publicado: (2021)

Drug induced hepatitis mimicking Wilson’s disease secondary to the use of complex naturopathic regimens: a case report
por: Pitre, Tyler, et al.
Publicado: (2019)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Molecular mechanism of copper transport in Wilson disease.
por: Fatemi, Negah, et al.
Publicado: (2002)

Intestinal expression of metal transporters in Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1g031b867kuvmtblocggmto6c1